LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.
Mark Identification

LIQUID BIOPSY IS REVOLUTIONIZING CANCER TREATMENT. NRICHDX EMPOWERS THAT REVOLUTION.

Serial Number

88250571

Filing Date

Jan 4, 2019

Registration Date

Nov 3, 2020

Trademark by

WAVESENSE INC.

Active Trademark

Classification Information

cell culture and cancer diagnostics tests, namely, liquid biopsy testing systems consisting of a specimen chamber assembly and magnetic materials used to sequester target analytes of interest within a liquid sample for isolation and characterization

Medical Apparatus